Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to $69.3 million.

  • Bicycle Therapeutics' Total Current Liabilities rose 2282.95% to $69.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year increase of 2282.95%. This contributed to the annual value of $67.2 million for FY2024, which is 331.77% down from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' Total Current Liabilities is $69.3 million, which was up 2282.95% from $77.4 million recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Total Current Liabilities registered a high of $77.4 million during Q2 2025, and its lowest value of $20.8 million during Q1 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $53.3 million (2022), whereas its average is $52.3 million.
  • As far as peak fluctuations go, Bicycle Therapeutics' Total Current Liabilities soared by 7763.5% in 2022, and later tumbled by 1911.64% in 2024.
  • Quarter analysis of 5 years shows Bicycle Therapeutics' Total Current Liabilities stood at $36.2 million in 2021, then skyrocketed by 47.2% to $53.3 million in 2022, then surged by 30.36% to $69.5 million in 2023, then dropped by 3.32% to $67.2 million in 2024, then increased by 3.05% to $69.3 million in 2025.
  • Its Total Current Liabilities stands at $69.3 million for Q3 2025, versus $77.4 million for Q2 2025 and $57.6 million for Q1 2025.